Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
| Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
|---|---|---|---|---|---|---|---|---|
| PINC55 | Effective Clinical Care | Appropriate Documentation of a Malnutrition Diagnosis | Process | Registry | Details | |||
| PIMSH9 | Effective Clinical Care | Oncology: Supportive Care Drug Utilization in Last 14 Days of Life | Efficiency | Registry | Details | |||
| PIMSH8 | Effective Clinical Care | Oncology: Mutation Testing for Lung Cancer Completed Prior to Start of Targeted Therapy | Process | Registry | Details | |||
| PIMSH4 | Person and Caregiver Centered Experience and Outcomes | Oncology: Patient-Reported Pain Improvement | Outcome | Registry | Details | |||
| PIMSH11 | Efficiency and Cost Reduction | Oncology: Utilization of PET, PET/CT, or CT scans for Breast Cancer stage 0, I, or II at any time during the course of evaluation and treatment | Process | Registry | Details | |||
| PIMSH10 | Patient Safety | Oncology: Hepatitis B Serology Testing and Prophylactic Treatment Prior to receiving anti-CD20 targeting drugs | Process | Registry | Details | |||
| PIMSH1 | Communication and Care Coordination | Oncology: Advance Care Planning in Metastatic Cancer Patients | Patient Engagement Experience | Registry | Details | |||
| ONSQIR23 | Effective Clinical Care | Assessment for and management of immune-related adverse events during cancer treatment with checkpoint inhibitors (ICPi) | Intermediate Outcome | Registry | Details | |||
| ONSQIR22 | Effective Clinical Care | PCR Test with MR2 or greater result (BCR-ABL1 transcript level <= 1% [IS]) for patients receiving TKI for at least 6 months for Chronic Myelogenous Leukemia | Intermediate Outcome | Registry | Details | |||
| ONSQIR21 | Person and Caregiver Centered Experience and Outcomes | Patient Reported Health-Related Quality of Life (HRQoL) during Treatment for Advanced Cancer | Outcome | Registry | Details | |||
| OEIS8 | Patient Safety | Use of ultrasound guidance for vascular access | Process | Registry | Details | |||
| OEIS7 | Efficiency and Cost Reduction | Structured Walking Program Prior to Intervention for Claudication | Process | Registry | Details | |||
| OEIS6 | Effective Clinical Care | Appropriate non-invasive arterial testing for patients with intermittent claudication who are undergoing a LE peripheral vascular intervention | Process | Registry | Details | |||
| OBERD32 | Person and Caregiver Centered Experience and Outcomes | Quality of Life - Physical Health Outcomes by Oberd | Outcome | Registry | Details | |||
| NPQR7 | Communication and Care Coordination | Time interval: critical value reporting for troponin | Process | Registry | Details | |||
| NPQR6 | Communication and Care Coordination | Time interval: critical value reporting for toxicology | Process | Registry | Details | |||
| NPQR5 | Communication and Care Coordination | Time interval: critical value reporting for cerebrospinal fluid - white blood cell (CSF - WBC) | Process | Registry | Details | |||
| NPQR4 | Communication and Care Coordination | Time interval: critical value reporting for chemistry | Process | Registry | Details | |||
| NPQR3 | Effective Clinical Care | Notification to the ordering provider requesting amylase testing in the diagnosis of suspected acute pancreatitis | Process | Registry | Details | |||
| NPQR2 | Effective Clinical Care | Notification to the ordering provider requesting thyroid screening tests other than only a Thyroid Stimulating Hormone (TSH) test in the initial screening of a patient with a suspected thyroid disorder | Process | Registry | Details |